TrialJACC. Heart failure2019

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Jonathan P Piccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.